Abstract:Background: MicroRNA-155-5p (miR-155-5p) has been reported to play an oncogenic role in different human malignancies; however, its role in Wilms tumor (WT) remains unclear. Methods: Differentially expressed miRNAs (DE-miRNAs) and mRNAs (DEGs) in WT blood and tissues were identified by using miRNA microarray and RNA-sequencing. Bioinformatics prediction and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were used to predict the potential functions of DE-miRNAs. DE-miRNAs and DEGs in WT obtained from Gene Expression Omnibus (GEO) and Therapeutically Applicable Research to Generate Effective Treatments (TARGET) were identified by using the "edgeR" package. RT-qPCR was used to explore miR-155-5p and IGF2 expression and their clinical significance in WT specimens. A rhabdoid cell line (G401) and Ewing sarcoma cell line (SK-NEP-1) were used. Immunohistochemical staining, western blotting and dual-luciferase reporter assays were performed to study the mechanisms involved. The CCK-8, flow cytometry, wound healing and transwell assays were performed to identify the effects of miR-155-5p and IGF2 knockdown on cell proliferation, apoptosis, migration and invasion, respectively. Results: MiR-155-5p was downregulated in both blood and tissues from WT patients who did not receive chemotherapy before surgery but was upregulated in tissues from WT patients who had received chemotherapy before surgery. IGF2, PI3K, AKT and mTOR were found to be upregulated in WT tissues. Additionally, miR-155-5p and IGF2 were significantly correlated with TNM stage and lymphatic metastasis in WT patients. Molecular mechanism exploration indicated that IGF2 was downregulated by miR-155-5p via direct binding to its 3' untranslated region in cell lines. Furthermore, IGF2, PI3K, AKT and mTOR expression was inversely correlated with miR-155-5p expression, and PI3K, AKT and mTOR expression was positively correlated with IGF2 expression in cell culture. Functional studies demonstrated that miR-155-5p upregulation and IGF2 knockdown suppressed cell proliferation, migration and invasion and induced cell apoptosis. Moreover, the tumor-suppressing effects of miR-155-5p in cells were abrogated by miR-155-5p inhibitor treatment. Conclusions: Taken together, these findings suggest that miR-155-5p functions as a tumor suppressor in WT through inactivating the PI3K/AKT/mTOR signaling pathway by directly targeting IGF2. Thus, miR-155-5p might be a novel therapeutic target for WT.

MiR-22-3p Regulates the Proliferation and Invasion of Wilms' Tumor Cells by Targeting AKT3.

MiR-155-5p Exerts Tumor-Suppressing Functions in Wilms Tumor by Targeting IGF2 Via the PI3K Signaling Pathway.

Silencing of Lncrna MEG8 Represses the Viability, Migration, and Invasion of Wilms’ Tumor Cells Through Mediating Mir-23A-3p/crk Axis

MiR-337 Suppresses Pancreatic Cancer Development Via STAT3/Wnt/β-catenin Axis.

MicroRNA‐501‐3p Inhibits the Proliferation of Kidney Cancer Cells by Targeting WTAP

miR-378c suppresses Wilms tumor development via negatively regulating CAMKK2

[Expression of miR-155-5p in Wilms tumor and its regulatory role in proliferation, migration and apoptosis of Wilms tumor cells in vitro].

Effect of miR-590-3p/DKK1 Axis on the Progression of Wilms' Tumour

MicroRNA-27a-5p Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis of Wilms’ Tumor Cell by Targeting PBOV1

ZMIZ1 Affects Invasion and Metastasis of Wilms Tumor by Regulating Notch Signaling Pathway

Microrna-187 Inhibits Pten Expression And Promotes Cell Proliferation In Non-Small-Cell Lung Cancer

Long Non-Coding RNA XIST Promotes Wilms Tumor Progression Through the Mir-194-5p/yap Axis.

Participations of TGFBRl and FGF9 in the Process of Mirna-140-5p Suppressing the Proliferation of Wilms’ Tumor

Wilms' Tumor 1 And Signal Transducers And Activators Of Transcription 3 Synergistically Promote Cell Proliferation: A Possible Mechanism In Sporadic Wilms' Tumor

HnRNPL Promotes Wilms Tumor Progression by Regulating the P53 and Bcl2 Pathways.

Role of the Wilms' Tumor 1 Gene in the Aberrant Biological Behavior of Leukemic Cells and the Related Mechanisms.

ZSTK474 targeting PIK3R3 inhibits the Wilms' tumor through G0 / G1 phase arrest

Investigating the Dysfunctional Pathogenesis of Wilms' Tumor Through a Multidimensional Integration Strategy.

RNA Sequencing Reveals a Regulatory Network of Circrna-Mirna-mrna Cerna in Wilms Tumor

Comprehensive Analysis of a Long Noncoding RNA-Associated Competing Endogenous RNA Network in Wilms Tumor

The synergistic effects of anoikis-related genes and EMT-related genes in the prognostic prediction of Wilms tumor